THSD7A and gastric cancer: The Kaplan–Meier Plotter tool validated the finding that patients with gastric cancer and low THSD7A expression had higher OS (P<0.001), first progression survival (FPS; P<0.001), and post-progression survival (PPS; P<0.001), compared with those with high THSD7A expression (Figure 3C–3E).